Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis: prevalence and the role of Cardiopulmonary Exercise Testing and echocardiogram in predicting it

G. Itamaro Heiden (São Paulo, Brazil), J. Barbosa Sobral (São Paulo, Brazil), J. Alves Jr (São Paulo, Brazil), J. Salge (São Paulo, Brazil), A. Albuquerque (São Paulo, Brazil), C. Fernandes (São Paulo, Brazil), R. Kairalla (São Paulo, Brazil), C. Ribeiro Carvalho (São Paulo, Brazil), R. Souza (São Paulo, Brazil), B. Guedes Baldi (São Paulo, Brazil)

Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Itamaro Heiden (São Paulo, Brazil), J. Barbosa Sobral (São Paulo, Brazil), J. Alves Jr (São Paulo, Brazil), J. Salge (São Paulo, Brazil), A. Albuquerque (São Paulo, Brazil), C. Fernandes (São Paulo, Brazil), R. Kairalla (São Paulo, Brazil), C. Ribeiro Carvalho (São Paulo, Brazil), R. Souza (São Paulo, Brazil), B. Guedes Baldi (São Paulo, Brazil). Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis: prevalence and the role of Cardiopulmonary Exercise Testing and echocardiogram in predicting it. 3684

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: